Checkpoint Trends Ltd

CHECKPOINTPharmaceuticals
121.50+0.00 (+0.00%)
As on 29 Jan 2026, 10:36 amMarket Closed

Fundamental Score

...

Checkpoint Trends Ltd Share Price Live NSE/BSE

No data
High
0.00
Low
0.00
Volume
0
Change
+0.00%

Profitability Metrics

Poor

Return on Equity

9.17%
Good

Return on Capital Employed

16.51%
Poor

Operating Profit Margin (5Y)

0.76%
Poor

Dividend Yield

0.00%

Valuation Metrics

Poor

Price to Earnings

38.20x

Market Capitalization

55.38 (Cr)

Industry P/E

31.77x

Growth Metrics

Excellent

YoY Quarterly Profit Growth

3400.00%
Excellent

YoY Quarterly Sales Growth

217080.00%
Poor

Sales Growth (5Y)

-12.77%
Excellent

EPS Growth (5Y)

37.97%
Excellent

Profit Growth (5Y)

37.97%

Financial Health

Excellent

Debt to Equity

0.00x

Interest Coverage

N/A
Average

Free Cash Flow (5Y)

0.23 (Cr)

Ownership Structure

Poor

Promoter Holding

0.00%
Good

FII Holding

10.86%
Poor

DII Holding

0.00%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.
0.00%
Promoter Holding
55.38 (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of CHECKPOINT across key market metrics for learning purposes.

Positive Indicators

7 factors identified

Excellent ROCE Performance (16.51%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.

Robust Profit Growth (3400.00%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.

Strong Revenue Growth (217080.00%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.

Excellent EPS Growth (37.97% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.

Strong Profit Growth Track Record (37.97% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.

Debt-Free Balance Sheet (D/E: 0.00)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

7 factors identified

Below-Average Return on Equity (9.17%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Margin Pressure Concerns (0.76%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges. Monitor for operational improvements.

Limited Growth History (-12.77% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities. Assess future growth catalysts.

Low Promoter Commitment (0.00%)

Observation: Reduced promoter stake may indicate limited confidence.

Analysis: Low promoter holding may raise questions about management commitment and long-term vision alignment.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.

High P/E Ratio

Observation: Stock may be overvalued relative to earnings.

Analysis: P/E above 30 requires strong growth execution to justify current valuations.

Small Market Cap

Observation: Higher investment risk due to limited size.

Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.

Financial Statements

Comprehensive financial data for Checkpoint Trends Ltd

About CHECKPOINT

Business Overview

Checkpoint Trends Limited engages in the trading business in India. It also provides management and other consultancy services. The company was formerly known as Rubra Medicaments Limited and changed its name to Checkpoint Trends Limited in May 2022. Checkpoint Trends Limited was incorporated in 1991 and is based in Mumbai, India.

Company Details

Symbol:CHECKPOINT
Industry:Pharmaceuticals
Sector:Pharmaceuticals

Key Leadership

Mr. Shubham Chaudhary
CFO & Whole Time Director
Ms. Artee Sahu
Company Secretary & Compliance Officer

CHECKPOINT Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)9.17%
Return on Capital Employed16.51%
Operating Profit Margin (5Y)0.76%
Debt to Equity Ratio0.00
Interest Coverage RatioN/A

Growth & Valuation

Sales Growth (5Y)-12.77%
Profit Growth (5Y)37.97%
EPS Growth (5Y)37.97%
YoY Quarterly Profit Growth3400.00%
YoY Quarterly Sales Growth217080.00%

Frequently Asked Questions

What is the current price of Checkpoint Trends Ltd (CHECKPOINT)?

As of 29 Jan 2026, 10:36 am IST, Checkpoint Trends Ltd (CHECKPOINT) is currently trading at ₹121.50. The stock has a market capitalization of ₹55.38 (Cr).

Is CHECKPOINT share price Overvalued or Undervalued?

CHECKPOINT is currently trading at a P/E ratio of 38.20x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.

What factors affect the Checkpoint Trends Ltd share price?

Key factors influencing CHECKPOINT's price include its quarterly earnings growth (Sales Growth: 217080.00%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Checkpoint Trends Ltd a good stock for long-term investment?

Checkpoint Trends Ltd shows a 5-year Profit Growth of 37.97% and an ROE of 9.17%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing.

How does Checkpoint Trends Ltd compare with its industry peers?

Checkpoint Trends Ltd competes with major peers in the Pharmaceuticals. Investors should compare CHECKPOINT's P/E of 38.20x and ROE of 9.17% against the industry averages to determine its competitive standing.

What is the P/E ratio of CHECKPOINT and what does it mean?

CHECKPOINT has a P/E ratio of 38.20x compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹38 for every ₹1 of annual earnings.

How is CHECKPOINT performing according to Bull Run's analysis?

CHECKPOINT has a Bull Run fundamental score of 44.7/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.

What sector and industry does CHECKPOINT belong to?

CHECKPOINT operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Checkpoint Trends Ltd.

What is Return on Equity (ROE) and why is it important for CHECKPOINT?

CHECKPOINT has an ROE of 9.17%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Checkpoint Trends Ltd generates profits from shareholders' equity.

How is CHECKPOINT's debt-to-equity ratio and what does it indicate?

CHECKPOINT has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.

What is CHECKPOINT's dividend yield and is it a good dividend stock?

CHECKPOINT offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.

How has CHECKPOINT grown over the past 5 years?

CHECKPOINT has achieved 5-year growth rates of: Sales Growth -12.77%, Profit Growth 37.97%, and EPS Growth 37.97%.

What is the promoter holding in CHECKPOINT and why does it matter?

Promoters hold 0.00% of CHECKPOINT shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.

What is CHECKPOINT's market capitalization category?

CHECKPOINT has a market capitalization of ₹55 crores, placing it in the Small-cap category.

How volatile is CHECKPOINT stock?

CHECKPOINT has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is the 52-week high and low for CHECKPOINT?

CHECKPOINT has a 52-week high of ₹N/A and low of ₹N/A.

What is CHECKPOINT's operating profit margin trend?

CHECKPOINT has a 5-year average Operating Profit Margin (OPM) of 0.76%, indicating the company's operational efficiency.

How is CHECKPOINT's quarterly performance?

Recent quarterly performance shows YoY Sales Growth of 217080.00% and YoY Profit Growth of 3400.00%.

What is the institutional holding pattern in CHECKPOINT?

CHECKPOINT has FII holding of 10.86% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.